The design and evaluation of epidemiological control strategies is central to public health policy. While inverse problem methods are routinely used in many applications, this remains an area in which their use is relatively rare, although their potential impact is great. We describe methods particularly relevant to epidemiological modeling at the population level. These methods are then applied to the study of pneumococcal vaccination strategies as a relevant example which poses many challenges common to other infectious diseases. We demonstrate that relevant yet typically unknown parameters may be estimated, and show that a calibrated model may used to assess implemented vaccine policies through the estimation of parameters if vaccine history is recorded along with infection and colonization information. Finally, we show how one might determine an appropriate level of refinement or aggregation in the age-structured model given age-stratified observations. These results illustrate ways in which the collection and analysis of surveillance data can be improved using inverse problem methods.
Introduction
Mathematical models have proven a beneficial tool for designing and evaluating prevention and treatment policies, particularly those associated with infectious diseases [2, 14] . Models are used to theoretically compare the effects of targeting prevention versus treatment, and some models have incorporated more sophisticated effects such as age-structure [21] , when relevant. Inverse problem methods have been used with surveillance data to calibrate structured population models [6, 7, 9, 10] . These calibrated models can then be used to make specific predictions concerning the impact of intervention policies on a particular population. Inverse problem methods can also be used to assess the effectiveness of policies once in place, and to determine the level of complexity needed in the modeling framework as warranted by the data. We demonstrate the use of mathematical modeling and inverse problem methods in conjunction with surveillance data as useful tools that should be put systematically in the hands of public health officials.
Here we illustrate the power of these approaches in the context of pneumococcal diseases, or infections caused by Streptococcus pneumoniae. Although isolated in 1881 [3] the infections caused by these bacteria are still a significant cause of morbidity and mortality, with estimates of 1 million annual deaths from pneumococcal pneumonia occuring in children under the age of five [35] . The development of pneumococcal vaccines is an active research area, raising questions concerning the design of effective strategies implementing novel vaccines. While the recent licensing of the PCV7 vaccine has been encouraging in light of the drastic reduction seen in infections, the long-term effects of its widespread use are unclear. In fact, an immunization program in Australia in which all children were provided the PCV7 free of charge (and 90% coverage obtained), was shown in [31] to be decreasingly effective during the first three years by similar methods employed here. The dynamics of these infections are dependent on many factors -notably, age, nutrition, climate, and the prevalence of serotypes endemic to the geographic region. As such, it is not likely that one strategy will be effective for all populations. Thus the use of the approaches in this manuscript using pneumococcal surveillance data to design and assess such strategies is particularly important.
New infections are the most common reported data type, however, the asymptomatic nasopharyngeal colonization that precedes infection is the stage during which horizontal spread occurs. Colonization is usually reversed in healthy individuals and does not follow the same age-prevalence profile as is seen with infections [1, 18, 26] . Some vaccines in development have the potential to protect against colonization by some or all of the over 90 pneumococcal serotypes and the monitoring of colonization prevalence has been considered of increasing importance. Whether to target either colonization, infection, or a combination of both is unclear (see [32] ). It is thought that targeting colonization may provide a previously unavailable ecological niche to other, potentially more invasive colonizers, not necessarily S. pneumoniae. Thus, programs using such vaccines would require constant monitoring, which can be effectively done using this framework.
In this paper, we describe the use of inverse problem methods with surveillance data and demonstrate these methods in an example using a pneumococcal disease dynamics population level model with simulated data. We discuss the inverse problem methods that are particularly well suited to contribute to the study of epidemiological processes and can aid in public health in Section 2. In Section 3 we outline a typical problem setup, or the information one needs to implement these methods. The necessary information includes a mathematical model (Section 3.1), any known parameters, usually available from sources such as census and scientific literature (Section 3.2), and surveillance data (Section 3.3). The data used here was generated to be similar to that commonly collected by public health departments. In Section 4, we perform computations to demonstrate the use of the methods described here with our example. We attempt to highlight some problems that arise commonly in practice and outline ways to address those difficulties.
The discussion in Section 4.4 is intended to illustrate tools which can be used to guide the appropriate level of sophistication in theoretical studies, and potentially in data collection. In some cases, ignoring age-dependent effects can result in a loss of information. In others, the inclusion of effects that are not warranted in the data can result in unnecessary sophistication and computational difficulty. In Section 4.4.1, we use simulated data, aggregated in nonuniform age classes to illustrate methodology for the determination of the optimal level of refinement necessary. In particular, we demonstrate the use of a model comparison statistic, to help determine when the structure of the population should be explicitly incorporated and when it can be ignored. Lastly, in Section 4.4.2 we use a model, which has been previously developed and calibrated in [31] with surveillance data from Australia to demonstrate this test as a means to guide the biological mechanisms included in a model.
Inverse problem methods
In this section, we outline some inverse problem methods relevant to epidemiological modeling in combination with surveillance data. The kinds of methods and issues discussed here also arise in other applications in which dynamical systems models are used to increase understanding of some physical or biological process. While the methods presented here are not novel (indeed, a more complete discussion of these and other related methods can be found in [5] ), their use with problems in this area (and other closely related applications) is nontrivial and uncommon. The pertinent techniques are generally described here, noting areas where difficulties are likely to arise. The general discussion presented in this section will allow us to refer only to the specific methodological issue at hand in the computational studies contained in Section 4.
The inverse problem methods outlined here address the use of longitudinal observations to give insight to our understanding of the underlying process. For the meaningful use of these observations with a mathematical model of an infectious disease, we need to interpret the observations in the context of model quantities. That is, we need to define an operator C, possibly nonlinear, to related observations y j to model state variables x(·;θ), or where θ is a vector of model parameters.
The definition of the observation operator C, should be done carefully and with particular attention to the data on hand and indeed, the validity of the computational results relies on whether or not this has been done correctly. For example, a classical SIR model without demographics, typical in population-level epidemiological modeling, consists of the following system of ordinary differential equations:
It is not likely that a set of data would have direct observations of individuals in each class. Particularly rare are counts of those who are susceptible S, or even recovered R. It is likely that we have some measure of the infective individuals I for given time points, but more commonly, the number of new infections during a time period are recorded. The observation operator in the first case would be linear, for example, where the operator is a diagonal matrix, C = diag{0, 1, 0}. In the second case, the operator would be nonlinear functional (involving an integral) mapping a trajectory of the state variables to a point y j , so that The information (parameters and/or variables) that we would be able to quantify from these two distinct kinds of observations are not equivalent. It is clear that a misrepresentation of the observations, and hence an ill-defined operator C would compromise any reported results.
We remark that it is not necessary to observe all state variables directly for these methods to be fruitful in providing information on the system of interest. Additionally, these methods do not depend on a complete set of longitudinal data, that is, if observations are reported on a monthly basis but a few months' observations are missing, the methods are still valid and can be quite useful. We will discuss both of these points more extensively later in this section.
We also outline methods to use with surveillance data to determine an appropriate mathematical model for the observed process. The level of detail built into a mathematical model is a key question to consider, particularly when the model is used with observations of the process. The goal is to provide a sufficiently accurate description of the process that will allow the investigators to answer relevant questions, but to do so as simply as possible for computational tractability as well as ease of comprehension of the model and its results. To illustrate those techniques, we use statistical methods to determine how many age classes should be included in our example model, which is structured by age. The methods are also useful when it is not clear whether a specific mechanism occurs (or is observable in the current data set), and thus whether it should be included in the model. To that end, we determine whether a term, representing an additional infection mechanism, should be included in a previously published ( [31] )model of pneumococcal disease dynamics with the actual surveillance data used in that paper.
Statistical model of observations
The observations will not usually correspond exactly to the observation process as computed by the model. These discrepancies are due to measurement or observation error and minor fluctuations not included in the mathematical model governing the dynamics of the state variables x(t). We first discuss the case where the y j 's are scalar, y j ∈ ℝ.
A reasonable statistical model of a process generating observations Y j considered here is: (1) where f(t j ; θ) = C j (x(·; θ), for j = 1, …, n longitudinal observations. The parameters θ ∈ Θ ⊂ ℝ p where Θ is a feasible parameter space, and x ∈ ℝ N , f ∈ ℝ m . As seen in the discussion of the two types of observations above, the operator C can take values of the state variables x at a fixed time t j (C: ℝ N → ℝ), or it can be a functional, taking a trajectory of x to a scalar y j (C : , termed the observation error. The observation error is generated from a probability distribution and therefore, the observations themselves, which depend on this error, is also a random variable.
It is common to assume that the ∈ j are independent and identically distributed and E [∈ j ] = 0 and var [∈ j ] = σ 2 for all j = 1, …, n. The expectation assumption is appropriate if it is thought that the counting process is just as likely to over-or under-estimate a measurement. The constant variance assumption is suitable if the error is not likely to change over time, nor is it likely to be related to the magnitude of the measurement itself. These assumptions give rise to an ordinary least squares (OLS) estimator, which will be used in this manuscript, and will be discussed in detail later in this section. Many times, these assumptions are acceptable in practice, for example, the assumptions seemed to be suitable for the surveillance data in [31] . Also, if very little is known about the measurement process, OLS is a good first step and one can relax or refine assumptions later if need be.
A common alternative to these assumptions is to assume that the variance is proportional to the magnitude of the observation itself var [∈ j ] = σ 2 f 2 (t j ; θ). For example, if a measurement process is likely to give a result that is +/− 10 for an observation of ≈ 300 and then it may is also likely be within 100 for an observation of ≈ 3,000. This would result in a generalized least squares estimator, which we will not concern ourselves with in this work. Another option is to assume the full distribution of the observation error, enabling us to use maximum likelihood techniques. If we assume, in addition to E[∈ j ] = 0, var [∈ j ] = σ 2 , and ∈ j being i.i.d.
for j = 1, …, n, that they are normally distributed (∈ j ~ N(0, σ 2 )), then the maximum likelihood estimator and the OLS estimator are equivalent. For further discussion of these and other estimation techniques, see [5] .
Ordinary least squares estimation
The least squares approach is based upon the idea of generally minimizing the difference between data Y j and the model f(t j ; θ). Under the assumptions listed in Section 2.1, the ordinary least squares (OLS) estimator is given by (2) where Y = (Y 1 , …, Y n ) T . Note θ OLS (Y) is a random variable, depending on Y which is also a random variable. The 'OLS' subscript is suppressed throughout the remainder of this manuscript as no other estimators will be discussed.
If a set of data, or one realization y = (y 1 , …, y n ) T , are used in (2), one can compute an estimate θ. That is, we seek to estimate θ 0 by finding parameters θ̂ which minimize, over feasible parameter space Θ, the distance between the model and a given set of data y.
This estimator is equivalent to an estimate for θ 0 via a maximum likelihood approach under the assumption of normality for the observation error. The GLS estimator has a slightly different form and is discussed in many sources, including [5] , [19] .
We can also estimate the variance in the observational error, σ 2 by (3) which has been adjusted for bias.
If there are multiple types of data, i.e. f(t j ; θ) ∈ ℝ m with m > 1, relevant to the same process, we can use them simultaneously in an OLS estimator and likely improve either the number and/or quality of the parameter estimates. With different types of data, arising from different counting or measurement processes, we should allow for the observational errors to have different variances. We use the superscript 'i' to denote which type of data for i = 1, …, m types. Then we have m operators Again, an estimate θ̂ is obtained by using a set of observations , or a realization of in (4). The bias-adjusted estimate of V is then
The computation of θ̂ in the vector case involves the variance of the observational error V. This difficulty is overcome by implementing an iterative procedure, which results in the simultaneous estimation of θ̂ and V. The procedure is summarized as follows:
1.
Guess initial values for V̂ and solve for an initial estimate θ̂( 0) using (4). Set k = 1.
2.
Using θ̂ = θ̂( k) , calculate V̂ using the expression in (5).
3.
Increment k by 1. Estimate θ̂( k) by minimizing (4) with V̂ from step 2.
4.
Re-estimate V̂ by (5) with θ̂ = θ̂( k) .
5.
Repeat steps 3 and 4, until two successive estimates for θ̂ are sufficiently close. Then take θ̂ = θ̂( k) and the current estimate for V.
Quantification of uncertainty
Parameter estimates alone are relatively meaningless unless accompanied by some measure of confidence in those values. The estimate of the variance in the observational error σ̂2 or V, provides some measure of uncertainty, but really only quantifies the variance in the observations. It is reassuring to an extent if this variance is small, indicating that the observation or measurement process is reasonably reliable. Further, it indicates that we have enough longitudinal data on hand to estimate this variance, as this estimate decreases with an increasing number of independent observations. But even so, the estimation process could be unreliable if, for example, there is little or no information in the data on the parameters estimated.
Nonlinear regression approximation theory ( [19] , [20] , [24] , and Ch 12 of [30] ) can be used to give information on the distribution to which the estimator θ(Y) converges asymptotically as n → ∞. Knowledge of this distribution allows us to make statements concerning its variance, which is one measure of reliability of the estimation process. For example, we can compute standard errors of the estimated parameters and construct confidence intervals, which we describe in this section. But it is important not to misinterpret these as a guarantee that the estimated parameters are necessarily 'close' to the true parameters. The true parameters are, and will remain unknown, but we can be somewhat reassured by an estimation procedure that gives consistent, or reliable results, as would be suggested by small standard errors or tight confidence intervals.
Again, we initially restrict the discussion to the scalar case (y j , f(t j ; θ), C are all scalar quantities). By the asymptotic theory for distributions, the sampling distribution for θ OLS is approximately a p-multivariate Gaussian under reasonable assumptions on smoothness and regularity (smoothness requirements are easily verified using continuous dependence results for differential equations in most cases, and regularity requirements involve, among others, conditions on the manner in which the sample size increases). The mean and variance of this
, respectively where Ω 0 is defined as (6) Under conditions outlined further in [30] we assume Ω 0 exists. Here χ(θ) is the n × p sensitivity matrix with elements (7) That is, for n large, the sampling distribution is approximately, (8) where the covariance matrix ∡ 0 is estimated by .
The entries for the sensitivity matrix χ can be computed numerically via forward differencing by where h l is a p-vector with zeros in all entries but in the lth component. However, the choice of h l can be problematic in practice, and an alternative is to solve a system of sensitivity equations. If our model of the system dynamics is ẋ = g(t, x(t),θ) then the N × p sensitivity equations are given by (9) In the vector OLS case, the covariance matrix is given by , where the m × p matrices, corresponding to each observation type, are
The sensitivities can be interpreted as reflecting the extent to which changes in parameters would result in different observations. That is, these quantities directly inform us as to which parameters we should be able to estimate from the given data. If the data is not sensitive to a parameter's value, then the estimate that we obtain is relatively arbitrary, and we could fit the data (minimize the residual) just as well with a different parameter value (or set of values). Thus studies with sensitivity equations can be used to determine which types of data should be collected if we want to estimate a certain parameter. Another related and recently developed technique, the study of generalized sensitivity equations ( [4] and [34] ) can be used to inform how to optimize data collection to yield information on parameter(s) of interest.
The standard error for each parameter, or the lth component of the parameter vector θ is given by
The standard errors are one measure of uncertainty in the estimated parameter value and it can also be used to compute a confidence interval. Once an acceptable level of confidence has been decided on, or α has been fixed for a 100(1 − α) * 100% confidence level, we seek to determine a range of parameter values such that
In the above expression, α ∈ (0, 1] is small and is computed from a Student's t distribution t n−p with n−p degrees of freedom. This is from defining the statistic then T ~ t n−p and the value is such that .
Model comparison statistic
Any model of a physical process may be improved upon, and models of infectious diseases are no exception. Increasing the level of detail in a model or including an additional mechanism would result in more parameters to be estimated. However, one can run the risk of overspecifying the problem and the additional information may not be supported by the surveillance data available. It may be that some terms, representing biological mechanisms, are not observed in the current system and should not be included in a model of the system. In this section, we describe a model comparison statistic, which describes how to determine if the reduction in residual is statistically significant when a more sophisticated model is used. There are other similar techniques that can be used to evaluate which model is more appropriate based on a given data set; these include the Akaike Information Criterion (AIC) selection procedure and its many variations as well as Bayesian model selection procedures ( [11] , [12] , [13] , [16] , [17] ).
Increasing the parameters estimated with a given set of data always results in a residual (value of the minimized objective functional) that is either the same or smaller than when fewer parameters are estimated. This is sometimes due to an improved fit of the model to the data and sometimes simply due to an increase in the degrees of freedom. In the case of one model being a special case of another, or a 'nested' model, there is a statistic which can be used to determine whether the reduced residual is statistically due to an improved fit.
Consider the estimator θ(Y) resulting from the minimization of model quantities f(t j , θ) and observations Y j for j = 1, …, n: (10) where Θ ⊂ ℝ p . We assume the same statistical model as before,
=σ 0 2 . The quantity θ 0 ∈ Θ again represents the 'true' parameters which generated the observations. Let θ̂ denote the estimate obtained from a realization of Y in which the objective functional has been minimized over Θ.
It may be that the true parameter is just as likely to lie within a sub-set Θ H ⊂ Θ which corresponds to the parameter θ being subject to some constraints. The set Θ H is defined by (11) where H is an r × p matrix of full rank, and c is a known constant. In the context of this paper, a model incorporating fewer age classes, and therefore having fewer dimensions of each agedependent parameter, will result in a minimization over a restricted parameter space. Let θ H denote the estimator given by (12) where a realization is used to obtain θ̂H. We would like to test the null hypothesis (13) The test statistic U n r (Y) is defined by (14) Asymptotic convergence results for U n (Y) similar to those in asymptotic sampling theory [30] are established in [8] , [9] . Then if H 0 is true, U n converges in distribution to U(r) as n → ∞ where U(r) ~ χ 2 (r), a χ 2 distribution with r degrees of freedom.
Then for a given significance level α, Prob{U n r > τ } = α for a threshold τ. We reject H 0 as false if Û n r > τ, or we do not reject H 0 as true if Û n r < τ at significance level α.
Problem formulation
To demonstrate these methods in the context of epidemiological modeling and surveillance data, we outline a situation where these methods could be useful. The vaccination of pneumococcal diseases is an active research area, involving questions of observed efficacy of new vaccines, as well as the manner in which surveillance data should be recorded (what type of information, how often, etc.). We present in Section 3.1 a mathematical model of pneumococcal disease dynamics, accounting for age explicitly. This is one example of incorporating biological complexity, although there are many other factors that may be more relevant depending on the specific problem. We immediately convert this model from its original partial differential equation formulation to a more tractable system of ODEs. Surveillance data is more readily interpreted in the framework of this model in terms of age cohorts. Next, in Section 3.2, we describe briefly which model parameters can be found from readily available sources, and which parameters in an epidemiological model typically need to be estimated via inverse problem methods. Lastly, in Section 3.3 we describe the data that we have generated to illustrate these concepts, which are typical of the kind of surveillance data routinely collected and some information that some public health agencies are considering collecting routinely.
Age-structured model of pneumococcal disease dynamics
We formulate a model in which n(a, t) denotes the density (in units of "number per age") of individuals of age a, a ∈ [0, ∞) at time t, t ∈ [0, ∞). This model and the underlying biological assumptions are described in more detail in [32] . These individuals are classified by their epidemiological state relevant to pneumococcal disease. Individuals are considered either susceptible S(a, t) to pneumococcal infection, asymptomatically colonized E(a, t) by S. pneumoniae, or infected I(a, t). Both susceptible S(a, t) and asymptomatically colonized individuals E(a, t) are effectively vaccinated at the age-dependent per capita vaccination rate ϕ (a), that is, they move to vaccinated states S V (a, t) and E V (a, t), respectively, at a rate proportional to ϕ(a). Vaccination is not always completely protective, even against vaccineincluded serotypes, thus there are also infected vaccinated individuals I V (a, t).
Transmission of S. pneumoniae occurs through respiratory droplets, and therefore the colonization process occurs as a result of an effective contact between a susceptible (or vaccinated susceptible) of age a at time t and a colonized or infected individual of any age a′ at time t, a process reflected in the effective contact rate c(a, a′).
The selected age-specific colonization rate λ(a, t) used here is given by (15) where λ(a, t) has units of . Colonization is typically reversed at the age-specific per capita rate α(a), or individuals progress to infection at the seasonal per capita rate κ(a, t). In vaccinated individuals colonization events are reduced by the factor 1 − ν(a) and infections are reduced
We assume that all individuals are born susceptible and unvaccinated, so the boundary conditions for the model are where f(a′) is the age-specific per capita fertility rate and
The model equations are given by the following initial boundary value problem:
Model (16 -21), while biologically reasonable, may be an unnecessarily difficult framework if the goal is to explore the impact of age-specific vaccination. The Appendix of [32] contains a derivation of a system of ordinary differential equations (ODEs) to approximate system (16)- (21) . The approach facilitates the aggregation of individuals into m age groups, describing the dynamics in terms of state variables where X is one of S, S V , E, E V , I, I V , or n. This approximation was introduced in [21] and is also applied in [22] and [23] . This gives the system: where the colonization rate is now given by All age-dependent rates (r(a)) are approximated by piecewise constant functions with at most m − 1 discontinuities, where χκ is the characteristic function on the age interval [aκ −1 , aκ ]. The length of the age intervals can vary. Smaller age intervals are taken in ranges where the dynamics of infections are likely changing drastically, i.e., the younger and older age ranges in the case of pneumococcal diseases.
'Known' or typically available information
We summarize here potential sources for finding parameter values that are typically needed in this and other population level epidemiological models. In the interest of remaining consistent with the present example, we report sources and values for one population (Australia) . All fixed values used in this study are summarized here in Table 1 Although there are no reliable reported values for the recovery rates, γk, our previous work with the unstructured model [31] , suggests that values within the physiologically feasible range , do not change results for the other estimated parameters. Due to lack of information, and also the insensitivity of other results to this parameter, we are not motivated to consider age-dependence of this parameter and therefore fix γ = γ 1 = … = γ 5 .
To simulate a population before the implementation of a new vaccine policy, portions of age groups 4 and 5 are vaccinated with the polysaccharide vaccine (PPV23), in accordance with the vaccination policies of most developed countries since the mid-1980s. Since this vaccine has had no observed effect on carriage, we set ν κ = 1 for κ = 1, …, 5 We have chosen 'true' parameter values (along with the initial conditions listed in Table 2 ) that produce annual infections by age that agree with reports available on the Australian NNDS website [18] . Additionally, these rates result in reasonable values for age-specific prevalences, based on scientific reviews and primary research papers, such as [1, 15, 25, 33] . The infections and colonization prevalences for these age groups as compared to the reported values are shown in Figure 2 . The initial conditions were chosen such that neither the population's age distribution nor the colonization prevalence changes significantly with time.
To simulate a newly implemented vaccine policy, targeting children, we increase the vaccination rate of age group 1. The pneumococcal conjugate vaccine is given at the ages of 2, 4, and 6 months, with a dose of PPV23 sometimes recommended for children aged 18-24 months. Since the booster is done rarely and therefore does not likely affect the infection dynamics at the population level, it is not specifically incorporated in these studies. In practice, one should use age intervals in the model to reflect the vaccine program of interest. We have not done that here since the purpose of this work is largely to illustrate the methodology and no specific vaccine policy is considered. Values for ρ have been chosen to consider vaccination protection only and excludes the natural immunity that typically develops as a result of exposure to pneumococcus over time. This natural immunity is absorbed in the infection rates. We update the values of δ 1 , δ 2 and ν1, ν2 to reflect a vaccine which has a protective effect against infection in the first two age groups, and a noticeable impact on colonization in the first three age groups. Updated 'true' parameter values for this situation are listed in Table 3 . Although controversial, the reduction of colonization by PCV7 and other conjugate vaccines has been documented for some serotypes and some say, for pneumococcal colonization prevalence overall. Other vaccines in development have the potential to have a stronger protective effect against the colonization stage, and therefore we include this as a mechanism in childhood vaccination considered here. Initial conditions, infection rates and effective contact rates are the unchanged from those used when only the adult vaccine is considered.
Surveillance data description
We generate data to simulate the kind of information that is available by surveillance programs. Some of the data generated are collected more commonly than others, and there have been recent discussions on which information should be reported. Thus, we demonstrate the benefits of generating data and using inverse problem methods to determine how useful the additional efforts in data collection may be. Total cases are commonly reported, although the age of the individual or vaccination status is not always recorded. Efficacy studies of developing pneumococcal vaccines occasionally incorporate nasal swabs of the studied population, which reveals the proportion of individuals colonized by S. pneumoniae, particularly since the long term effects of the vaccine on colonization are unknown. Recently, it has been suggested that public health departments should collect this kind of information on a regular basis and at a large scale to determine if any protective or potentially harmful effects have occurred. We discuss some benefits of these additional efforts as they relate to the process of assessing the impact of a vaccine policy on a surveyed population.
We generate four different types of simulated data according to the following forms:
•
Total cases: where j = 1, …, n 1 for each κ = 1, …, 5,
Vaccinated Cases: where j = 1, .., n 2 for each κ = 1, …, 5,
Colonization Prevalence: where j = 1, …, n 3 for each κ = 1, …, 5,
Vaccinated Colonized Prevalence: where j = 1, …, n 4 for each κ = 1, .., 5, where the number of longitudinal observations n 1 , n 2 , n 3 , n 4 are not necessarily equal. In practice, these quantities, and thus the observation operators C i , are defined based on the interpretation of the data. For instance, f (1,i) an integral over the infection rate is appropriate if the data is reported as the number of cases (new infections) over a period of time. Those observations do not have any information on how many individuals were already sick, or how long they stay sick, and so to interpret those reports as being the number of infectives at a fixed time or over a period of time would be erroneous.
In the computations to follow, we use these generated data to which noise has been added according to the statistical model in Equation (1) . Unless otherwise stated the variance in the observation error was scaled to be 10% the longitudinal average of the observations. That is for each data type i = 1, …, 4 and age group κ = 1, …, 5. Note that the variance is constant in time and therefore an OLS approach is appropriate.
Inverse problem methods applied to pneumococcal surveillance data

Model calibration via parameter estimation
Before we can reap the benefits of mathematical modeling of infectious diseases in a particular population (e.g., to theoretically study prevention and/or treatment scenarios), the first step is to calibrate the model to that population. This involves determining model parameter values that best represent the population, so that the model solutions correctly predicts the observed outcomes as accurately as possible. While many parameter values are readily available in literature, some of the most pertinent parameters to an epidemiological process are not directly measurable and therefore cannot be found in most sources. For example, infection rates are not commonly reported as they are not easily measured. However, we can estimate these rates for each age group from total case notification data Y 1~ f 1 , via an OLS approach. We remark that since the variances in observation error differed in magnitude across age classes , a vector OLS approach was necessary.
The parameter estimates and variance estimates for the observation error can be found in Table  4 . The best fit of the model to data with 2 years of total cases reported on a monthly basis is seen in Figure 3 . We see that we obtain better estimates (in the sense that the values are closer to the 'true' values and smaller standard errors) when the monthly recordings (n 1 = 24) are used as compared to the annual notifications n 1 = 6 (plots of the yearly reported data and model fits are not shown). This comparison involves a difference in reporting frequency, which can be thought of as 'missing' information if we consider annual data as sparsely reported monthly data. Since the parameters were reasonably estimated with only 6 longitudinal observations, we could conclude that it is sufficient to record this kind of data annually in the interest of estimating this parameter. Estimates would be improved in the case of annual data if more years were available, and in the absence of this it may be a better option to use monthly data to collect many observations in a shorter period of time.
In numerical experiments not shown here we have tested for the ability to estimate parameters using all forms of data Y 1 , .., Y 4 considered here and were not able to reliably estimate the recovery rate γ. In practice, it is sometimes the case that we are not able to estimate all unknown parameters. One way to address this problem is to explore how other estimated parameters might change in response to the recovery rates changing over the range . The results in Table 5 suggest that the parameter values and their standard errors are virtually unaffected by changes in the recovery rate in this range, which covers biologically reasonable values. This suggests that although the observations do not contain information on this parameter, it is not likely that fixing it at a value other than its true value would deter the calibration of the model.
Design of surveillance programs
The collection of additional information in surveillance programs requires additional resources, and therefore, it would be helpful to know if the increase in current efforts is worthwhile. We show in the context of our current example that we can estimate the effective contact rate, a parameter that is otherwise particularly difficult, if not impossible, to quantify.
Since collectively, the effective contact rates largely govern the level of colonization observed in a population, the colonization prevalence data Y 3 , Y 4 is most likely to contain the most information on the contact rates. However, when these data are used in the estimation process, the sensitivity of the data to the parameters is approximately zero, resulting in standard errors too large to be calculated due to a numerically singular matrix χ T χ. It is reasonable to approximate the time-dependent force of infection by a constant λ κ (t) ≈ λ κ since the colonization prevalence is relatively constant in time. Taking the 'true' values here as the mean of λ κ (t) for each i = 1, …, 5 over the 2 years of Y 3 data without noise, we can compare these values to estimates of from OLS estimation with 2 years of monthly (n 3 = 24) colonization prevalence observations Y 3 with 10% noise (Table 6 ). The parameter estimates shown in Table 6 are not as close to their true values as when the mean infection rates and vaccine protection from infection were estimated. However, standard errors are around an order of magnitude less than the parameter values with 10% noise present in the data, indicating that the estimates obtained are reasonably reliable.
While it was necessary to make a simplifying assumption in this case, this assumption would be possible for any disease which has remained at an endemic state over a period of time. Given the scarcity of information on both the force of infection and effective contact rates, it is likely advantageous to record colonization data and be able to obtain some quantification of these rates. The routine collection of colonization data has been considered recently by many public health departments in light of the development of vaccines which may impact this stage of infection.
Assessment of vaccine programs
To assess the effectiveness of a given vaccine program once it has been implemented, we would like to be able to measure the protection induced by the vaccine. The protection from infection factor 1 − δ κ or what is typically referred to as vaccine efficacy, can differ in practice from what is reported in vaccine efficacy studies. Therefore, it is important to discuss how to effectively estimate this parameter from surveillance data. In the case of pneumococcal infections, the colonized state is particularly relevant in disease dynamics, and the ability of some novel vaccines to affect this state is both controversial and promising. Experts have not agreed whether the conjugate vaccine has had a significant impact on colonization, nor if the impact would be advantageous or harmful. Thus, measuring the reduction of asymptomatic carriage due to vaccination ν 1 , ν 2 in the younger age classes is crucial to study the impact of recently developed vaccines, and those that are currently in development.
We use reports of vaccinated cases in the OLS procedure to estimate the protection from infection, and we now estimate this parameter for the vaccinated younger and older age classes {δ κ } κ =1,2,4,5 , shown in the third and fourth columns of Table 7 . Annual data are not used in this case since we are estimating 20 parameters simultaneously and would therefore need at least 21 years of data (as required by the standard variance σ 2 formula), which is likely not available in most cases. The seventh and eighth columns contain estimates of ν 1 , ν 2 from records of colonization prevalence in vaccinated individuals (Y 4 ), corresponding to nasal swabs in which vaccination information has been recorded. Since the estimates are relatively close to their true values, and the standard errors are small compared to the parameter values, these results suggest that data of these forms contain enough information on the parameters to reliably estimate them. In the last two columns of Table 7 , we see the results of estimating these parameters simultaneously from these data. The parameter estimates are relatively close to their true values and the standard errors for some of the parameters indicate that the estimates are still reasonably reliable if they are estimated simultaneously. Thus, information on one aspect of vaccine protection is not needed to estimate the other, and the unknown parameters may be reliably estimated simutaneously. This information is not currently routinely collected, thus we have demonstrated with these methods what could be gained if surveillance efforts included this type of data.
Collection of vaccination information involves additional resources and requires greater effort, and therefore may not always be a feasible option for some public health offices. Therefore, we have explored the possibility of estimating these parameters simultaneously from case notification and colonization data when vaccination information was not given for one type of data (not shown). Unfortunately, the parameter estimates do not converge to their true values, even when five years of monthly data is used in the estimation process. This suggests that an emphasis on the collection of vaccination information would be necessary should a vaccination program need to be assessed.
Model refinement
4.4.1 Age structure refinement-Additional information accompanying a data set, such as age, is usually beneficial, although the question of how much of this information should be incorporated to the model is not always clear. Including too much detail in a model can hinder computations and unnecessarily increase complexity. Here we present a discussion of the level of refinement that significantly improves agreement between the mathematical model and a set of observations. For this illustration, data has been generated by a model made up of 14 distinct age classes. The age classes are: (0,2] mos, (2, 4] ) . The methods used here apply to 'nested' models so this is the most discretized version of age groups, and all other models will consider only aggregations of these age groups. Table 8 are the 'true' values for the mean infection rates which were used to generate the 'data'. The infection rates among the first 4 age classes differ the most although the intervals are the of the shortest length; thus it is expected that the age-dependence in this range is important. In contrast, the infection rates among the last five age classes are relatively similar. If we consider these age classes as distinct, we will obtain an 'improved fit' indicated by a smaller residual. However, whether this reduction indicates a significant improvement requires the use of the statistical test described in Section 2.4.
Contained in
Consider the model which aggregates the ages into the following 5 age classes: (0,2] yrs, (2, 15] yrs, (15, 50] , (50,65], (65, ∞). Fitting this model to data which has been aggregated according to the constraint Hθ = 0 where H is an 9 × 14 matrix, of which the first 5 rows are given by Thus, the constraints are κ 0,1 = κ 0,2 = κ 0,3 = κ 0,4 , κ 0,5 = κ 0,6 = κ 0,7 , and κ 0,10 = … κ 0,14 . Imposing this constraint we obtain the results in the fit shown in Figure 4 . The model does not appear to agree well with the data, and it is clear that some information has been lost. However, this would not be obvious if the 5 age group model fit is plotted with the data that has also been grouped into the same age classes, as seen in Figure 5 . The residual calculated from the fit seen in Figure 4 is used in the model comparison statistic. We let denote the residual from the 14 age-class model fit to infection data and denote that from the model with 5 age classes fit to data. The test statistic is then (42) which is compared to χ 2 distribution with 9 degrees of freedom. As reported in Table 9 , even with a significance level of 99.5%, we would reject the null hypothesis in this case. The null hypothesis is that the true parameters θ 0 lie within the constrained parameter space Θ H = { θ ∈ Θ|Hθ = 0}. Thus, this suggests that the additional information provided by considering a finer age discretization does result in a significant improvement in the model agreement to the 'observations'. That is, a researcher would be reasonably motivated to include the additional detail in the model when studying these data. Table 9 contains the relevant quantities for determining an appropriate level of age structure refinement. The age classes have been grouped together for the intervals shown in the top row. Comparing the first with the second column of numerical values we find there is a marked decrease in residual as the age structure is included in the younger ages. It is unclear from inspection whether the residual in the case of the second column is sufficiently close to that of the fully discretized (14 age-class) model to justify the grouping in ages (2, 15] and over 65. However, the test statistic is greater than the threshold value for the very high significance level used here, indicating that even in this case, we should reject the null hypothesis. That is, the improvement in the data fit here is significant and the additional detail in these age classes should be incorporated. When only the age groups over 65 have been aggregated, the residual appears close to the fully discretized model and the statistic supports the null hypothesis. In fact, even for a low significance level of α = 0.25, Û > τ = 5.39. In this case, one would be justified in ignoring the age intervals over 65.
4.4.
2 Biological complexity refinement-The model comparison statistic can also be used to determine whether an additional biological mechanism should be incorporated into model. The result of this test should not be interpreted as proof that this mechanism does or does not occur necessarily, but it can be used to say whether or not it is observed in the available data.
For example, we can use the statistical test was to show that exogenous reinfection did not occur substantially in the surveillance data used in [31] , from the Australian National Notifiable Diseases Surveillance website [18] . The model in that paper did not incorporate age explicitly and is given by: Exogenous reinfection is the establishment of an infection within a colonized individual through repeated exposure to S. pneumoniae via contacts with other individuals harboring the bacteria. This mechanism is included in the above model by the infection term in the unvaccinated classes and in the vaccinated classes. This is equivalent to the model in [31] with β 2 = 0, and thus they can be considered 'nested'. We compare fits to data for the cases β 2 = 0 and β 2 ≠ 0.
Case notification data was used, the interpretation of which must be modified to reflect the additional infection mechanism, so that the number of new cases is now (49) where j = 1, …, 36. We estimate parameters θ = (β 1 , κ 0 , κ 1 , δ, β 2 ) T now from these 36 monthly cases, and from the corresponding annual reports of which of these cases were vaccinated or unvaccinated. These data are represented by and From the n = 42 observations, Y j , approximated by the model quantities f(t j , θ), we seek to estimate parameters θ = (β 1 , κ 0 , κ 1 , δ, β 2 ) T . We obtain these estimates via a least squares estimation process in which our estimate for θ minimizes an objective function, J n (θ). When f(t j , θ) is that for the more sophisticated model above, where Θ ⊂ ℝ 6 is the (compact) feasible parameter space. The known linear function H: ℝ 6 → ℝ 5 for our example is then The results from the estimation procedures are shown in Table 10 . The parameter estimates themselves, θ̂ and θ, do not differ significantly. Although, the standard errors indicate that our ability to estimate β and κ(t) does change drastically depending on whether or not the two mechanisms of infection are considered. When the reinfection term is considered, we see that the standard error for this particular parameter indicates that our data does not provide a significant amount of information on this process. However, the smaller residual, RSS, when the objective functional is minimized over a less restricted parameter space (when β 2 ≠ 0), might indicate that is a better fit. To resolve these two seemingly contrasting pieces of information, we turn to the test statistic to determine if the difference in residuals is enough to justify the inclusion of this extra infection rate.
The test statistic can be calculated as Note that the residual sum of squares is the value of the objective function, so that RSS = J n (θ). We compare this to χ 2 (1) table and see that even at a significance level of α = 0.25 we would accept our null hypothesis. That is, the difference in residuals, and hence the improvement of fits of model solution to data, is not enough to warrant including the additional infection mechanism. This does not mean that it does not occur, but it does suggest that to accurately capture the dynamics of the population, as evidenced by the surveillance data, it is reasonable to neglect this term. Therefore, we conclude that 'reinfection' does not occur sufficiently to necessitate this term in models of the infection dynamics.
Conclusions
Mathematical modeling can provide a great deal of insight into physical processes, particularly when inverse problem methods are used to understand observations of the underlying system. The study of infectious diseases has been greatly enhanced by modeling and control scenarios have been designed and improved as a result of these efforts. Recently, the need to make these efforts more quantitative and relevant via connection to data has become increasingly clear. However, the use of these methods are still not commonplace. We have described here existing methods that have potential to impact epidemiological modeling. We have illustrated the use of theoretical and computational inverse problem methods as a means to effectively use surveillance data with mathematical modeling in the study of infectious diseases. An agestructured model of pnemococcal disease dynamics incorporating vaccination was used as a relevant example. The development of new pneumococcal vaccines have raised questions concerning the effective vaccination of a population and how to effectively collect surveillance information to monitor the dynamics of infection.
Noisy simulated data, representative of what is typically collected, was used to illustrate the estimation of model parameters such as infection rates. In these studies we illustrated some common issues that may arise in practice and discussed possible solutions or alternatives. It is not possible to directly observe many of these parameters within a population, yet they govern many key processes of an epidemic. Thus the use of inverse problem methods to estimate parameters allows for the calibration of a model to a population. With a calibrated model, public health officials would be able to quantitatively predict the impact of a disease, and to prescribe prevention strategies, such as vaccine programs. Once a vaccination strategy is implemented, a calibrated model can then be used to estimate parameters that would be changed.
Additionally, surveillance programs can be improved via these methods, enabling us to anticipate if proposed additional efforts in data collection would be fruitful. To this end, we demonstrated the generation of data like the surveillance data that would be collected to perform preemptive estimation studies. These studies allow us to use computations to determine if the desired information is contained in the data before any resources are used in data collection.
With many data sets, there typically comes additional information, such as age, geographical location, and strain or serotype information. Whether to include this information in theoretical studies and at what level of detail is not always clear by inspection of the data. We have described via a model comparison statistic how one might determine a suitable refinement of age groups given a set of age-stratified data. Such a tool is useful to elucidate important aspects of disease dynamics, and perhaps underlying mechanisms driving disease persistence that should be targeted by control strategies. Additionally, this test provides a safeguard against unnecessary computational and data collection challenges.
We used a previously developed model of pneumococcal disease dynamics [31] in conjunction with Australian surveillance data to demonstrate the model comparison statistic as a means to determine whether a biological mechanism should be incorporated in a model. This technique is particularly useful in modeling, as we always strive to achieve a balance between simplicity and an accurate description of the process. This illustrates one way in which simulated "observations" can be used as a guideline to develop more accurate models. Pneumococcal infection dynamics with vaccination as a function of age. Reported and model calculated infections (left) and colonization prevalences (right) by age. Model fit to 2 years of monthly case notifications (n 1 = 24). In the above legends, 'data 1' indicates the simulated data for age group 1, 'model 1' refers to the model solution for age group 1, 'data 2' is the plot of the data for age group 2, and so on. The model fit to 6 years (n 1 = 6) of simulated data is not shown. Model with 5 age classes plotted with infection data grouped into 14 age classes. Again, in the legends above 'data' refers to the plotted simulated observations, 'model' indicates the corresponding model solutions, and the number indicates the age class. Model with 5 age classes plotted with infection data grouped into 5 age classes. Best fit model solutions to monthly case notifications with constant variance error. Table 2 Parameters and initial conditions used to generate data for model calibration studies. Table 3 Parameters used to generate data simulating the implementation of a novel vaccine program. Table 4 Estimates of from 6 years of annual case notification data (Y (1) ) are shown in columns 3 and 4. Estimates of Ψ from 2 years of monthly case notification data are shown in columns 5 and 6. The true values, which were used to generate the data, are denoted by Ψ 0 , and are shown in column 2.
Note that the values for for the annual data are significantly larger than those for the monthly data since they are scaled by the observations and there are significantly more infections that occur in a year than a month. 
Table 5
Estimates of from 2 years of monthly total case notification data (Y 1 ), where the recovery rates have been fixed at , γ = 1, γ = 2 for i = κ, …, 5. Table 6 Estimates of from 2 years of colonization prevalence data (Y 3 ) with 0 and 10% noise, where the level of noise is denoted by a superscript. Table 10 Parameter estimates without and with 'exogenous reinfection'. 
